PG

Priya Ghosh

Director Director DIN 08300757
DIN 08300757 First appointment Dec 2018 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2018
Shareholding value •••• Premium profile

About Priya Ghosh

Data last updated:

Priya Ghosh was a Director at Dermasons Life Sciences Private Limited (2022–2023) and Director at Glemderma Pharmaceutical Private Limited (2018–2023). The companies operate in Chemicals and Pharma.

DIN 08300757
Primary Designation Director
Industry Chemicals
First Appointment 11 Dec 2018

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Oct 20222022Active
Director11 Dec 20182018₹7.5 Lakh (FY 2020)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dermasons Life Sciences Private Limited
Glemderma Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Priya Ghosh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priya Ghosh

Priya Ghosh was first appointed on 11 Dec 2018 as Director at Glemderma Pharmaceutical Private Limited. The most recent appointment on record is 07 Oct 2022 at Dermasons Life Sciences Private Limited.

Priya Ghosh held 2 earlier board appointments: Dermasons Life Sciences Private Limited (Director, 07 Oct 2022 to 17 Apr 2023); Glemderma Pharmaceutical Private Limited (Director, 11 Dec 2018 to 17 Apr 2023).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available